Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CXXC4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KLC1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PHLDA2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | GAGE2E | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TMEM267 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NDUFV1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KIAA1586 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MT-ND4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
mRNA | NHLH1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |